Director Shareholding
01 Agosto 2008 - 9:41AM
UK Regulatory
Eden Research plc
1 August 2008
Eden Research plc ("Eden Research" or the "Company")
Correction - Directors' Shareholdings
On 11 July 2008, Eden Research issued two announcements regarding the shareholdings of Stephen O'Brien
and Sir Ben Gill, both non-executive directors of the Company.
It was stated that Stephen O'Brien holds 47,059 shares representing 0.8% of the Company's issued share
capital and Sir Ben Gill holds 39,603 shares, representing 0.7% of the Company's share capital. The
percentages were incorrectly calculated and the correct percentages are as set out below:
Director Total shares held Percentage of issued share
capital
Stephen O'Brien 47,059 0.08%
Sir Ben Gill 39,603 0.07%
Eden Research has 56,313,274 ordinary shares in issue.
For further information, please contact:
Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844
Jonathon Brill/Caroline Stewart, Financial Dynamics
T: 020 7831 3113
About Eden Research plc
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development
of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene
chemistry and other patented environmentally friendly technologies. Eden is currently working
alongside universities and partner companies in developing its product portfolio towards
commercialisation.
For further information please visit www.edenresearch.com.
Eden Research plc
Edenville (LSE:EDE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Edenville (LSE:EDE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Edenville (London Stock Exchange): 0 recent articles
Más de Eden Research Plc Artículos de Noticias